Philip Adeyemi Adeniyi

Dr. Philip Adeyemi Adeniyi

Department of Pediatrics, Oregon Health & Science University, Portland, Connecticut, USA
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2023 in Annals of Neurology
Verified
Journal Article
Open access
Philip Adeyemi AdeniyiPhilip Adeyemi Adeniyi
Philip Adeyemi Adeniyi
XGXi Gong
Xi Gong
EMEllie MacGregor
Ellie MacGregor
KDKiera Degener‐O'BRien
Kiera Degener‐O'BRien
EMEvelyn McClendon
Evelyn McClendon
SBStephen A. Back
Stephen A. Back
Objective: Because the role of white matter (WM) degenerating microglia (DM) in remyelination failure is unclear, we sought to define the core features of this novel population of aging human microglia.Methods: We analyzed postmortem human brain tissue to define a population of DM in aging WM lesions. We used immunofluorescence staining and gene expression analysis to investigate molecular mechanisms related to the degeneration of DM.Results: We found that DM, which accumulated myelin debris were selectively enriched in the iron‐binding protein light chain ferritin, and accumulated PLIN2‐labeled lipid droplets. DM displayed lipid peroxidation injury and enhanced expression for TOM20, a mitochondrial translocase, and a sensor of oxidative stress. DM also displayed enhanced expression of the DNA fragmentation marker phospho‐histone H2A.X. We identified a unique set of ferroptosis‐related genes involving iron‐mediated lipid dysmetabolism and oxidative stress that were preferentially expressed in WM injury relative to gray matter neurodegeneration.Interpretation: Ferroptosis appears to be a major mechanism of WM injury in Alzheimer's disease and vascular dementia. WM DM are a novel therapeutic target to potentially reduce the impact of WM injury and myelin loss on the progression of cognitive impairment. ANN NEUROL 2023;94:1048–1066

13 November 2013 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
OOOlalekan Ogundele
Olalekan Ogundele
AOAdams Olalekan Omoaghe
Adams Olalekan Omoaghe
DADuyilemi Chris Ajonijebu
Duyilemi Chris Ajonijebu
AOAbiodun Ayodele Ojo
Abiodun Ayodele Ojo
TFTemitope Deborah Fabiyi
Temitope Deborah Fabiyi
Philip Adeyemi AdeniyiPhilip Adeyemi Adeniyi
Philip Adeyemi Adeniyi

31 May 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Tanya GandhiTanya Gandhi
Tanya Gandhi
CCCade R. Canepa
Cade R. Canepa
TATolulope T. Adeyelu
Tolulope T. Adeyelu
Philip Adeyemi AdeniyiPhilip Adeyemi Adeniyi
Philip Adeyemi Adeniyi
Charles LeeCharles Lee
Charles Lee
Autism spectrum disorder (ASD) is associated with neurodevelopmental alterations, including atypical forebrain cellular organization. Mutations in several ASD-related genes often result in cerebral cortical anomalies, such as the abnormal developmental migration of excitatory pyramidal cells and the malformation of inhibitory neuronal circuitry. Notably here, mutations in the CNTNAP2 gene result in ectopic superficial cortical neurons stalled in lower cortical layers and alterations to the balance of cortical excitation and inhibition. However, the broader circuit-level implications of these findings have not been previously investigated. Therefore, we assessed whether ectopic cortical neurons in CNTNAP2 mutant mice form aberrant connections with higher-order thalamic nuclei, potentially accounting for some autistic behaviors, such as repetitive and hyperactive behaviors. Furthermore, we assessed whether the development of parvalbumin-positive (PV) cortical interneurons and their specialized matrix support structures, called perineuronal nets (PNNs), were altered in these mutant mice. We found alterations in both ectopic neuronal connectivity and in the development of PNNs, PV neurons and PNNs enwrapping PV neurons in various sensory cortical regions and at different postnatal ages in the CNTNAP2 mutant mice, which likely lead to some of the cortical excitation/inhibition (E/I) imbalance associated with ASD. These findings suggest neuroanatomical alterations in cortical regions that underlie the emergence of ASD-related behaviors in this mouse model of the disorder.

20 June 2015 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
Philip Adeyemi AdeniyiPhilip Adeyemi Adeniyi
Philip Adeyemi Adeniyi
AIAzeez O. Ishola
Azeez O. Ishola
BLBabafemi J. Laoye
Babafemi J. Laoye
BOBabawale P. Olatunji
Babawale P. Olatunji
OBOluwamolakun Bankole
Oluwamolakun Bankole
OOOlalekan M. Ogundele
Olalekan M. Ogundele

1 December 2016 in Pathophysiology
Verified
Journal Article
Closed access
Philip Adeyemi AdeniyiPhilip Adeyemi Adeniyi
Philip Adeyemi Adeniyi
EOE.P. Omatsuli
E.P. Omatsuli
AAA.J. Akinyemi
A.J. Akinyemi
AIA.O. Ishola
A.O. Ishola

27 September 2022 in ASN Neuro
Verified
Journal Article
Open access
Philip Adeyemi AdeniyiPhilip Adeyemi Adeniyi
Philip Adeyemi Adeniyi
KFKatie-Anne Fopiano
Katie-Anne Fopiano
FBFatima Banine
Fatima Banine
MGMariel Garcia
Mariel Garcia
XGXi Gong
Xi Gong
SBStephen A. Back
Stephen A. Back
A major limitation of mechanistic studies in aging brains is the lack of routine methods to robustly visualize and discriminate the cellular distribution of tissue antigens using fluorescent immunohistochemical multi-labeling techniques. Although such approaches are routine in non-aging brains, they are not consistently feasible in the aging brain due to the progressive accumulation of autofluorescent pigments, particularly lipofuscin, which strongly excite and emit over a broad spectral range. Consequently, aging research has relied upon colorimetric antibody techniques, where discrimination of tissue antigens is often challenging. We report the application of a simple, reproducible, and affordable protocol using multispectral light-emitting diodes (mLEDs) exposure for the reduction/elimination of lipofuscin autofluorescence (LAF) in aging brain tissue from humans, non-human primates, and mice. The mLEDs lamp has a broad spectral range that spans from the UV to infrared range and includes spectra in the violet/blue and orange/red. After photo quenching, the LAF level was markedly reduced when the tissue background fluorescence before and after mLEDs exposure was compared (p < 0.0001) across the spectral range. LAF elimination was estimated at 95 ± 1%. This approach permitted robust specific fluorescent immunohistochemical co-visualization of commonly studied antigens in aging brains. We also successfully applied this method to specifically visualize CD44 variant expression in aging human cerebral white matter using RNAscope fluorescent in-situ hybridization. Photo quenching provides an attractive means to accelerate progress in aging research by increasing the number of molecules that can be topologically discriminated by fluorescence detection in brain tissue from normative or pathological aging.